147 related articles for article (PubMed ID: 23903999)
1. Renal function in a rat model of neurogenic bladder, effect of statins and phosphodiesterase-5 inhibitors.
Mirzaii-Dizgah I; Salmanyan B
Eur Spine J; 2013 Dec; 22(12):2766-9. PubMed ID: 23903999
[TBL] [Abstract][Full Text] [Related]
2. The effects of PDE5 inhibitory drugs on renal ischemia/reperfusion injury in rats.
Küçük A; Yucel M; Erkasap N; Tosun M; Koken T; Ozkurt M; Erkasap S
Mol Biol Rep; 2012 Oct; 39(10):9775-82. PubMed ID: 22736111
[TBL] [Abstract][Full Text] [Related]
3. Urethral dysfunction and therapeutic effects of a PDE 5 inhibitor (tadalafil) in a rat model of detrusor underactivity induced by pelvic nerve crush injury.
Takaoka EI; Kurobe M; Suzuki T; Shimizu N; Kwon J; Okada H; Yoshimura N; Chermansky CJ
Neurourol Urodyn; 2020 Mar; 39(3):916-925. PubMed ID: 32040866
[TBL] [Abstract][Full Text] [Related]
4. Differential vasoactive effects of sildenafil and tadalafil on cerebral arteries.
Kruuse C; Gupta S; Nilsson E; Kruse L; Edvinsson L
Eur J Pharmacol; 2012 Jan; 674(2-3):345-51. PubMed ID: 22094063
[TBL] [Abstract][Full Text] [Related]
5. Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.
Toque HA; Priviero FB; Zemse SM; Antunes E; Teixeira CE; Webb RC
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):358-66. PubMed ID: 18986324
[TBL] [Abstract][Full Text] [Related]
6. The selectivity and potency of the new PDE5 inhibitor TPN729MA.
Wang Z; Zhu D; Yang X; Li J; Jiang X; Tian G; Terrett NK; Jin J; Wu H; He Q; Yang B; Shen J
J Sex Med; 2013 Nov; 10(11):2790-7. PubMed ID: 23937247
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of phosphodiesterase-5 inhibitors on hypoxic pulmonary vasoconstriction and pulmonary artery cytokine expression.
Tsai BM; Turrentine MW; Sheridan BC; Wang M; Fiore AC; Brown JW; Meldrum DR
Ann Thorac Surg; 2006 Jan; 81(1):272-8. PubMed ID: 16368379
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil attenuates placental ischemia-induced hypertension.
George EM; Palei AC; Dent EA; Granger JP
Am J Physiol Regul Integr Comp Physiol; 2013 Aug; 305(4):R397-403. PubMed ID: 23785075
[TBL] [Abstract][Full Text] [Related]
9. Additive effect of tadalafil and simvastatin on monocrotaline-induced pulmonary hypertension rats.
Zhang WH; Liu CP; Zhang YJ; Ji YQ; Lu WX; Zeng Q
Scand Cardiovasc J; 2012 Dec; 46(6):374-80. PubMed ID: 22971207
[TBL] [Abstract][Full Text] [Related]
10. Repurposing PDE5 inhibitor tadalafil and sildenafil as anticancer agent against hepatocellular carcinoma via targeting key events of glucose metabolism and multidrug resistance.
Chhonker SK; Rawat D; Koiri RK
J Biochem Mol Toxicol; 2022 Aug; 36(8):e23100. PubMed ID: 35608386
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin and sildenafil combine to attenuate pulmonary hypertension.
Zhao L; Sebkhi A; Ali O; Wojciak-Stothard B; Mamanova L; Yang Q; Wharton J; Wilkins MR
Eur Respir J; 2009 Oct; 34(4):948-57. PubMed ID: 19797670
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, and tadalafil in rat aorta.
Teixeira CE; Priviero FB; Webb RC
J Pharmacol Exp Ther; 2006 Feb; 316(2):654-61. PubMed ID: 16204472
[TBL] [Abstract][Full Text] [Related]
13. Presence of phosphodiesterase type 5 in the spinal cord and its involvement in bladder outflow obstruction related bladder overactivity.
Füllhase C; Hennenberg M; Giese A; Schmidt M; Strittmatter F; Soler R; Gratzke C; Andersson KE; Stief C
J Urol; 2013 Oct; 190(4):1430-5. PubMed ID: 23545097
[TBL] [Abstract][Full Text] [Related]
14. Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue.
Uckert S; Sormes M; Kedia G; Scheller F; Knapp WH; Jonas U; Stief CG
Urology; 2008 Mar; 71(3):526-30. PubMed ID: 18342202
[TBL] [Abstract][Full Text] [Related]
15. Oral phosphodiesterase-5 inhibitors: effect of heme oxygenase inhibition on cGMP signalling in rat cavernous tissue.
Abdel Aziz MT; Mostafa T; Atta H; Rashed L; Marzouk SA; Obaia EM; Sabry D; Hassouna AA; El-Shehaby AM; Abdel Aziz AT
Andrologia; 2007 Apr; 39(2):66-70. PubMed ID: 17430426
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O
Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639
[TBL] [Abstract][Full Text] [Related]
17. The role of PDE5 inhibitors in heme oxygenase-cGMP relationship in rat cavernous tissues.
Aziz MT; Mostafa T; Atta H; Rashed L; Marzouk SA; Obaia EM; Sabry D; Hassouna AA; El-Shehaby AM; Aziz AT
J Sex Med; 2008 Jul; 5(7):1636-45. PubMed ID: 18208506
[TBL] [Abstract][Full Text] [Related]
18. Comparative relaxing effects of sildenafil, vardenafil, and tadalafil in human corpus cavernosum: contribution of endogenous nitric oxide release.
Toque HA; Priviero FB; Teixeira CE; Claudino MA; Baracat JS; Fregonesi A; De Nucci G; Antunes E
Urology; 2009 Jul; 74(1):216-21. PubMed ID: 19371941
[TBL] [Abstract][Full Text] [Related]
19. Effects of the phosphodiesterase 5 inhibitor Tadalafil on bladder function in a rat model of partial bladder outlet obstruction.
Kawai Y; Oka M; Yoshinaga R; Fuchikami C; Oyama T
Neurourol Urodyn; 2016 Apr; 35(4):444-9. PubMed ID: 25703926
[TBL] [Abstract][Full Text] [Related]
20. Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.
González-Corrochano R; La Fuente J; Cuevas P; Fernández A; Chen M; Sáenz de Tejada I; Angulo J
Br J Pharmacol; 2013 May; 169(2):449-61. PubMed ID: 23441682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
